4//SEC Filing
Lamond David 4
Accession 0001209191-23-057799
CIK 0001662774other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 6:30 PM ET
Size
10.5 KB
Accession
0001209191-23-057799
Insider Transaction Report
Form 4
Lamond David
Director
Transactions
- Purchase
Common Stock
2023-12-05$1.01/sh+19,123$19,314→ 2,241,418 total(indirect: By Trust) - Purchase
Common Stock
2023-12-06$1.02/sh+19,123$19,505→ 2,260,541 total(indirect: By Trust) - Purchase
Common Stock
2023-12-07$1.01/sh+19,123$19,314→ 2,279,664 total(indirect: By Trust)
Holdings
- 301,829
Common Stock
- 1,734,722(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.99 to $1.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F3]Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the "2006 Trust") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001770790
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 6:30 PM ET
- Size
- 10.5 KB